Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

Digital health funding slowed in 2019

Global venture capital funding in digital health dropped 6% in 2019, with 615 deals nabbing $8.9 billion in capital.

Thumbnail

Teladoc acquires InTouch for $600M

Virtual care provider Teledoc Health will acquire InTouch Health for the purchase price of $600M.

Thumbnail

ACO savings are clear, but participation drops

Accountable care organizations are increasingly saving Medicare more money, but after the Trump administration made significant changes to the Medicare Shared Savings Program, fewer of these organizations are participating, according to data from the National Association of Accountable Care Organizations (NAACOS).

Thumbnail

Sky-high drug prices could hurt Republicans in 2020

Drug prices are still rising, with manufacturers hiking up prices at the start of 2020. And the “reluctance” from the Republican party to challenge those rising prices could become a huge liability for the upcoming 2020 election, according to The Hill.

Thumbnail

Drug price inflation slows under investor strategy

Drug prices are still rising in 2020, but the rate of inflation appears to be slowing down. For investors, however, that might be good news, according to The Wall Street Journal.

Thumbnail

Hospital charges are driving higher payments

Hospital charges are on their way up, driving up private payments that are already significantly higher than public payments, according to a new study published in Health Affairs. However, the widening gap between private and public payments appears to be slowing down.

 

Thumbnail

CVS, Walgreens, others sue doctors over opioid crisis role

A handful of major drugstore retailers are suing Ohio doctors over their role in the national opioid abuse and overdose epidemic, claiming pharmacies alone shouldn't be found liable in litigation.

Thumbnail

White House shares new AI principles, calling for healthy collaboration and limited regulation

The White House has proposed a new set of principles for governing the development of AI solutions throughout the United States.

Displaying 857 - 864 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup